The Xpert MTB/Ultra molecular diagnostic test may become a viable option for detecting tuberculosis (TB) in the stool of ...

The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic ...

The FDA reviewed this test under the FDA’s De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk ...

As with other tests, the main risks of using the Visby test are the possibility of false-negative results, leading to delays in treatment, or false-positive results, leading to unnecessary treatment.

The US Food and Drug Administration (FDA) has granted marketing authorization for the first at-home test to diagnose ...

President Trump’s FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis ...

US FDA grants marketing authorization of first home test for Chlamydia, gonorrhoea and trichomoniasis: Silver Spring, Maryland Monday, March 31, 2025, 10:00 Hrs [IST] The US Food ...

The US Food and Drug Administration has approved a single-use at-home test which can detect three STIs in women. Read on to ...

The FDA has approved the first at-home, nonprescription test for chlamydia, gonorrhea, and trichomoniasis in women. The Visby ...

(A more accurate rapid test is less available ... (it is often linked with HIV, and men in particular are reluctant to be tested), but there are also many false negatives because of weak sputum ...